Weight-Loss Drugs Help Sleep Apnea Symptoms
Eli Lilly & Co.’s weight-loss drug Zepbound improved breathing problems in highly anticipated studies that may convince more insurers to cover the $1,000-a-month treatment.
In two late-stage trials of patients with obstructive sleep apnea, a condition closely linked to obesity, Zepbound reduced the number of times breathing slowed or stopped during sleep by up to 63% from the baseline, Lilly said in a statement Wednesday. The result topped Jefferies analysts’ expectations that the trials would likely show a reduction of about 50% to 55%.
[time-brightcove not-tgx=”true”]
Patients in...
Source: TIME: Health - April 17, 2024 Category: Consumer Health News Authors: Madison Muller/Bloomberg Tags: Uncategorized bloomberg wire healthscienceclimate Source Type: news
Most Of Lilly's Mounjaro and Zepbound Doses in Limited Supply, FDA Says Most Of Lilly's Mounjaro and Zepbound Doses in Limited Supply, FDA Says
Most doses of Eli Lilly ' s diabetes drug Mounjaro and weight-loss drug Zepbound would be in limited supply through the second quarter of this year due to increased demand,...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Antidepressants Tied to Mortality in T2D, but Cause Unclear Antidepressants Tied to Mortality in T2D, but Cause Unclear
Antidepressant use may be a marker for more severe and unsuccessfully treated depression.Medscape UK (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 17, 2024 Category: Internal Medicine Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Too Little Sleep Raises Health Risks for Teens With T1D Too Little Sleep Raises Health Risks for Teens With T1D
Sleeping for more than 7 hours at night may improve cardiometabolic health in patients with type 1 diabetes, especially teenagers, showed an analysis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Clinical Summary Source Type: news
Placenta Plays Role in Gestational Diabetes, Study Suggests
WEDNESDAY, April 17, 2024 -- The placenta could be one reason why some women develop gestational diabetes during pregnancy, a new study finds.A deficit in the way the placenta expresses the gene for a hormone called insulin-like growth factor 1... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2024 Category: General Medicine Source Type: news
Some Gut Bugs May Help Lower Your Cholesterol
WEDNESDAY, April 17, 2024 -- Changes in gut bacteria have been linked to a variety of different diseases, including type 2 diabetes, obesity and inflammatory bowel disease.Now, a new study indicates that gut bacteria also might play a role in a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 17, 2024 Category: General Medicine Source Type: news
Eli Lilly's Weight-loss Drug Succeeds in Trials With Sleep Apnea Patients Eli Lilly's Weight-loss Drug Succeeds in Trials With Sleep Apnea Patients
Eli Lilly ' s weight-loss drug helped cut the frequency of irregular breathing in patients with obstructive sleep apnea by as much as 63% on average across two late-stage...Reuters Health Information (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 17, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
Lilly's Weight-loss Drug Reduces Sleep Apnea Severity in Late-stage Trials Lilly's Weight-loss Drug Reduces Sleep Apnea Severity in Late-stage Trials
Eli Lilly said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials,...Reuters Health Information (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 17, 2024 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news
Lawmakers Take Up Fallout From Change Healthcare Cyberattack
(MedPage Today) -- Over $1,000 for diabetes test strips? That's what one patient was told he would have to pay during the Change Healthcare cyberattack earlier this year, a lawmaker said at a House Energy & Commerce Health Subcommittee hearing... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 16, 2024 Category: Primary Care Source Type: news
Brenzavvy vs Farxiga for T2D; PFAS in Seafood; 100 Deaths Linked to GLP-1 Drugs?
(MedPage Today) -- Bexagliflozin (Brenzavvy) and dapagliflozin (Farxiga) induced similar HbA1c reductions over 24 weeks in a head-to-head phase III trial of the SGLT2 inhibitors in Chinese adults with type 2 diabetes on metformin. (Journal of Diabetes... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - April 16, 2024 Category: Endocrinology Source Type: news
Can Thyroid Dysfunction Cause Hormonal Imbalance? Can Thyroid Dysfunction Cause Hormonal Imbalance?
When to suspect that thyroid dysfunction is responsible for a hormonal imbalance, and how to determine whether it is the cause.American Thyroid Association (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - April 16, 2024 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Commentary Source Type: news
Increased Retinopathy Risk Seen With GLP-1RAs for Diabetes Increased Retinopathy Risk Seen With GLP-1RAs for Diabetes
But diabetes-related eye complication risks were reduced with SGLT2 inhibitors and insulin.Medscape News UK (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 16, 2024 Category: Primary Care Tags: Internal Medicine Clinical Summary Source Type: news
Diabetes training programme ‘instilling confidence’ in GPNs
A programme designed to support general practice nurses (GPNs) to deliver diabetes clinics in Scotland has provided ‘instant understanding and confidence’ among the workforce. The NHS Grampian Supporting Practice Nurses in Diabetes, Revalidation and Appraisal programme (SANDRA) was founded in November 2019 to support nurses looking to provide more diabetes care, and as experienced GPNs... Read moreThe post Diabetes training programme ‘instilling confidence’ in GPNs appeared first on Nursing in Practice. (Source: Nursing in Practice)
Source: Nursing in Practice - April 16, 2024 Category: Nursing Authors: Madeleine Anderson Tags: Clinical Diabetes Latest news Source Type: news
Neutral Result With Novel Agent in Diabetic Cardiomyopathy Neutral Result With Novel Agent in Diabetic Cardiomyopathy
The ARISE-HF trial testing aldose reductase inhibition in asymptomatic diabetic cardiomyopathy did not meet its endpoint but hints at a mechanism that might prevent it.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 16, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
Ozempic Hurts the Fight Against Eating Disorders
It’s impossible to escape the soaring popularity of Ozempic and similar drugs these days—daily headlines, celebrity “success” stories, and apparent ease in procuring prescriptions (even Costco sells them now) abound. But the cumulative effect of all of this has many experts in the eating disorder field worried about how this might affect their patients. This makes sense—even for those without eating disorders, these drugs can feel both triggering and enticing. After all, research tells us about 90% of women are dissatisfied with their bodies. This sounds like a quick fix.
[time-brightcove not-...
Source: TIME: Health - April 16, 2024 Category: Consumer Health News Authors: Cole Kazdin Tags: Uncategorized freelance Source Type: news
